Cite
APA Citation
Weiss, B., Plotkin, S., Widemann, B., Tonsgard, J., Blakeley, J., Allen, J., Schorry, E., Korf, B., Rosser, T., Goldman, S., Vinks, A., Cutter, G., Dombi, E., Ratner, N., Packer, R., & Fisher, M. (n.d.). nFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY. Neuro-oncology, 20(2), i143. http://access.bl.uk/ark:/81055/vdc_100095485048.0x000018